Claim of OpenAI investment in cancer-detecting brain implants remains unverified

The claim that OpenAI invested in a startup developing cancer-detecting brain implants could not be independently verified. The available material did not establish the recipient, investment amount or terms, leaving insufficient evidence to describe a completed deal.

Coherence Neuro is developing SOMA, an implant system intended to monitor cancer and deliver electrical stimulation. Its company materials describe a technology under development, rather than demonstrated clinical effectiveness. Those materials do not establish the claimed OpenAI investment.

OpenAI separately confirmed an investment in Merge Labs on January 15, 2026. That announcement describes research into brain-computer interfaces and collaboration on AI tools, but does not announce an investment in cancer-detecting implants. Confirmation of the claimed transaction remains outstanding.